REDFILED Newsdesk

A utility-scale solar farm of the type planned under the Tadaa and Kainan partnership.

TGL

TREASURE GLOBAL (TGL) Unit Joins $367M, 360 MW Malaysian Solar Farm Project

Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.

A natural gas wellhead of the kind found across Pennsylvania's Marcellus shale.

ALP

ALPHA COMPUTE (ALP) Buys 300 Acres of Pennsylvania Gas Land for $5.5M

Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.

PALI

FDA Clears PALISADE BIO IND for PALI-2108 in Crohn's Disease

Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.

PDSB

PDS (PDSB) BIOTECH Phase 2 Data Published in JAMA Oncology With 39.3-Month Survival

VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.

Enlivex has cancelled a planned share issue that would have been paid for in digital tokens.

ENLV

ENLIVEX (ENLV) Terminates $66.7M-Share Private Placement With Rain Foundation

The Israeli biotech has scrapped a July agreement to issue 66,666,667 ordinary shares to the Rain Foundation, which had elected to pay in RAIN tokens.

Filana Therapeutics is preparing a Phase 2a trial of simufilam in patients with drug-resistant seizures linked to tuberous sc

FLNA

FDA Lifts Clinical Hold on FILANA's Simufilam in TSC Epilepsy

Filana Therapeutics can start a 40-patient Phase 2a study of simufilam in TSC-related epilepsy, with screening expected by the first quarter of 2027.

Beam Global plans to manufacture drones in its existing U.S. and European factories.

BEEM

BEEM Signs LOI to Buy European Drone Maker in Pivot to Defense

Beam Global plans to acquire an unnamed European drone and AI software company and build a Pentagon conditionally approved drone system in the U.S.

Tonix's Tonmya is the first new prescription treatment approved for fibromyalgia in more than 15 years.

TNXP

TONIX (TNXP) Lands Second Managed Medicare Deal for Fibromyalgia Drug Tonmya

Tonix says a second managed Medicare agreement adds about 21 million lives, lifting total payer coverage for Tonmya to roughly 166 million U.S. lives.

Tegoprubart is being developed to prevent rejection in kidney transplant recipients.

ELDN

ELEDON (ELDN) Reports 24-Month Phase 2 Kidney Data and Wins FDA Fast Track

Tegoprubart kept kidney function about 13 mL/min/1.73 m² above tacrolimus at month 24, as Eledon prepares to start its Phase 3 LEGACY trial in Q4.

Viking Therapeutics is developing VK2735 in both injectable and oral formulations for obesity.

VKTX

VIKING THERAPEUTICS (VKTX) Says VK2735 Holds Weight Loss on Monthly Dosing

Maintenance study shows patients kept up to 97% of weight loss on every-other-week dosing and up to 90% on monthly dosing, with GI side effects near placebo.

Chronic spontaneous urticaria causes recurring hives and itching.

CLDX

CELLDEX (CLDX) Phase 3 Trials of Barzolvolimab Hit All Endpoints in Hives

Both EMBARQ-CSU studies met primary and all key secondary endpoints, with complete response rates above 42% at week 12; BLA planned for 2027.

Alpha Compute is acquiring more than 75 existing oil and gas wells in Pennsylvania.

ALP

ALPHA COMPUTE (ALP) Buys Pennsylvania Oil and Gas Assets for $5.5 Million

The Nasdaq-listed AI infrastructure company signed binding agreements for 300-plus acres of surface, mineral and gas rights plus 75 producing wells.